Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities

Preventive Measures Clinical Trial

— Get Screened  

Official title:

Primary Care Based Randomized Trial to Reduce Cancer Screening Disparities

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00818857
• Other study ID #: RSRB 00025557
• Status: Completed
• Phase: N/A
• First received: January 6, 2009
• Last updated: June 16, 2016
• Start date: January 2009
• Est. completion date: February 2013

Study information

• Verified date: June 2016
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this project is to improve cancer screening rates within practices serving low-income minority patients

Description:

This project is designed to implement and rigorously evaluate a cancer screening quality improvement project within a practice serving underserved patients. The project involves use of a patient registry coupled with patient reminders,recall and outreach.All unscreened patients will receive the benefit of this intervention, though some sooner than others for the purpose of evaluation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1072
• Est. completion date: February 2013
• Est. primary completion date: October 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years to 75 Years

Eligibility

Inclusion Criteria:

• Men age 50-75 yrs.

• Women age 40-75 yrs

• One primary care visit in past 2 years.

Exclusion Criteria:

• High risk for colorectal or breast cancer.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Preventive Measures

Intervention

Behavioral:
• Early Intervention
At the point of randomization the early group will receive increasingly intensive reminders to complete specific cancer screening tests.
• Delayed intervention
One year from the point of randomization patients will begin to receive increasingly intensive reminders to complete specific cancer screening tests.

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
University of Rochester	American Cancer Society, Inc.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To test for differences in rates of screening between the early intervention and delayed groups, the chi-square test will be used for each outcome.		End of project, 12/2011	No